US EditionRecor Medical's Paradise System Gains Approval In Japan
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Otsuka Medical Devices Announces Japan Approval of Paradise uRDN System - Endovascular Today
August 25, 2025—Otsuka Medical Devices Co., Ltd. announced that the Paradise ultrasound renal denervation (uRDN) system has received manufacturing and marketing approval in Japan for the treatment of resistant hypertension. The Paradise uRDN system was developed by Recor Medical, Inc., a United States–based subsidiary of Otsuka Medical Devices. According to Otsuka Medical Devices, approval in Japan was based on the results of the RADIANCE-HTN TR…
Otsuka Medical Devices Announces Japan Approval of Paradise uRDN System - Cardiac Interventions Today
August 25, 2025—Otsuka Medical Devices Co., Ltd. announced that the Paradise ultrasound renal denervation (uRDN) system has received manufacturing and marketing approval in Japan for the treatment of resistant hypertension. The Paradise uRDN system was developed by Recor Medical, Inc., a United States–based subsidiary of Otsuka Medical Devices. According to Otsuka Medical Devices, approval in Japan was based on the results of the RADIANCE-HTN TR…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
